226 related articles for article (PubMed ID: 8293835)
1. Comparative study: Replens versus local estrogen in menopausal women.
Nachtigall LE
Fertil Steril; 1994 Jan; 61(1):178-80. PubMed ID: 8293835
[TBL] [Abstract][Full Text] [Related]
2. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
[TBL] [Abstract][Full Text] [Related]
3. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
[No Abstract] [Full Text] [Related]
4. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
5. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
8. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial shows lasting function of a new moisturizing cream against vaginal dryness.
Henneicke-von Zepelin HH; Williams R; Havemeister W; Wigger-Alberti W; Nolte KU
Wien Med Wochenschr; 2017 May; 167(7-8):189-195. PubMed ID: 28091974
[TBL] [Abstract][Full Text] [Related]
10. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function.
Hubbard GB; Carey KD; Levine H; Bachmann GA
Lab Anim Sci; 1997 Feb; 47(1):36-9. PubMed ID: 9051645
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
[TBL] [Abstract][Full Text] [Related]
13. Systemic absorption and sustained effects of vaginal estrogen creams.
Martin PL; Yen SS; Burnier AM; Hermann H
JAMA; 1979 Dec; 242(24):2699-700. PubMed ID: 228093
[TBL] [Abstract][Full Text] [Related]
14. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
Bygdeman M; Swahn ML
Maturitas; 1996 Apr; 23(3):259-63. PubMed ID: 8794418
[TBL] [Abstract][Full Text] [Related]
15. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.
Vale F; Rezende C; Raciclan A; Bretas T; Geber S
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women.
Suwanvesh N; Manonai J; Sophonsritsuk A; Cherdshewasart W
Menopause; 2017 Feb; 24(2):210-215. PubMed ID: 27749740
[TBL] [Abstract][Full Text] [Related]
18. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women.
Tersigni C; Di Simone N; Tempestilli E; Cianfrini F; Russo R; Moruzzi MC; Amar ID; Fiorelli A; Scambia G; Villa P
J Obstet Gynaecol; 2015; 35(8):835-8. PubMed ID: 25968636
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
20. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry.
van der Laak JA; de Bie LM; de Leeuw H; de Wilde PC; Hanselaar AG
J Clin Pathol; 2002 Jun; 55(6):446-51. PubMed ID: 12037029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
